Clinical Trials in Arizona

Showing 13141-13160 of 16,770 trials

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00003762

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two regimens of docetaxel plus gemcitabine in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Lung Cancer

Alliance for Clinical Trials in Oncology106 participantsStarted Feb 1999

Scottsdale, Arizona, United States • Urbana, Illinois, United States • Cedar Rapids, Iowa, United States +14 more locations

COMPLETEDPhase 231 miles

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

NCT00006483

RATIONALE: Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood and may be an effective treatment for patients with kidney cancer that has spread to the lung. PURPOSE: Phase II trial to study the effectiveness of sargramostim in treating patients who have kidney cancer that has spread to the lung.

Kidney CancerMetastatic Cancer

Alliance for Clinical Trials in Oncology27 participantsStarted Oct 2000

Scottsdale, Arizona, United States • Peoria, Illinois, United States • Urbana, Illinois, United States +21 more locations

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Find Trials by Condition in Arizona

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy

ICI 182780 in Treating Women With Metastatic Breast Cancer

Everolimus in Treating Patients With Stage IV Melanoma

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])

Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding